From March 5th to 7th, 2026, the 2026 Diagnosis and Treatment Expo will grandly open at the Chengdu Wuzhouqing Exhibition Center, with the core theme of "Resonance." This year's exhibition focuses on the pulse of primary healthcare development, addressing the central issue of "how to counter internal competition and seek symbiosis in the era of active health." The event will gather industry peers to explore highly efficient new healthcare paths through multi-party collaboration, becoming a key exchange platform to resolve the current "structural game" dilemmas in primary healthcare.

WBL Medical Group at the Diagnosis and Treatment Expo - Booth T12

WBL LIPUS: From Technological Breakthrough to Full-Spectrum Coverage

As the first company in the industry to appear on CCTV's "Science and Technology China" program, Beijing WBL Medical Group has been invited to participate in this industry grand event. At Booth T12, the company will showcase an innovative product lineup covering the full process from "detection - diagnosis - treatment - rehabilitation." Among them, the WBL LIPUS low-intensity pulsed ultrasound ED treatment cabin will be the core product, impressively debuting. This product continues the LIPUS core technology, which won the international IDEA Design Award, and was initiated by Academician Guo Yinglu of the Chinese Academy of Engineering. It was developed through international collaboration with the teams of Professors Lv Futai and Lin Guiting from the University of California, San Francisco (UCSF), and Professor Xin Zhongcheng from Peking University First Hospital. This marks an upgrade of the WBL LIPUS technology from a "treatment system" to a "scenario-based platform."

Highlight 1: WBL LIPUS Technological Innovation

The treatment cabin is made with medical-grade 5A polymer absorbent materials and incorporates micro-computer numerical control recognition technology to ensure precise and convenient operation. The internal space design prioritizes privacy and humanistic care, earning it the industry title of "Male Health Space Capsule." The core technology of this treatment system continues the LIPUS principle, utilizing pulsed ultrasound of specific intensity to activate endogenous stem cells in the penile corpus cavernosum, repairing damaged or aging tissue, promoting vascular and nerve regeneration, and improving erectile function at its pathological roots. The treatment is non-invasive, does not require anesthesia, has no side effects, and has been included in expert consensus. It has become the clinical first-choice in over 20 top-tier hospitals nationwide. Compared to traditional treatment equipment, this cabin innovatively implements a "technology-based treatment + psychological counseling + rehabilitation guidance" approach, using a VR panoramic assistance system to relieve psychological stress. Each treatment course requires only 8-10 sessions to achieve significant improvement, perfectly aligning with the primary healthcare demand for "efficiency, safety, and ease of operation."

Highlight 2: WBL LIPUS Innovative Products

Also showcased are several core complementary products that form a complete diagnostic and treatment loop:

1. The extracorporeal pulsed ultrasound pelvic floor treatment platform is the first extracorporeal ultrasound technology used for the treatment of male chronic inflammation / chronic pelvic pain syndrome (CPPS). It offers non-invasive treatment, promotes tissue repair, and effectively alleviates pain and urinary symptoms.

2. Penile Hardness Measurement Instrument JH-ED1100: Based on international gold standard detection principles, it provides monitoring data for identifying the causes of ED and evaluating treatment efficacy.

3.Neuro-Sensitivity Instrument JH-TSA-1000: Equipped with high-sensitivity detection technology to capture nerve conduction signals, helping primary healthcare institutions implement a standardized path for "precise diagnosis - targeted treatment."

Collaborative Technological Value: From Breakthroughs to Ecological Co-construction

This year’s Diagnosis and Treatment Expo emphasizes the theme of "Resonance," advocating for the resolution of development challenges through alignment of direction, role return, and system coordination. WBL Medical Group’s presence at Booth T12 will feature live demonstrations of the LIPUS treatment cabin, in-depth sharing of clinical cases, and technical principle explanations, offering primary healthcare institutions practical, "full-chain + scenario-based" diagnostic and treatment solutions. These solutions range from the objective diagnosis using the penile hardness measurement instrument to precise treatment with the LIPUS cabin and long-term intervention with the pelvic floor rehabilitation platform, creating a distinctive service system that covers both male and female health, helping primary healthcare evolve from "single-point competition" to "comprehensive service symbiosis."

As a benchmark company adhering to "technology-driven health ecology," WBL continues to prioritize clinical needs, relying on international research collaborations and localized transformations to bring tertiary hospital-grade technologies to primary healthcare. Their participation in the Chengdu event with the LIPUS treatment cabin is both an active response to the trends of the era of active health and a precise empowerment to meet the primary healthcare demand for "quality improvement and efficiency enhancement."

We look forward to gathering with industry peers at Booth T12, where real-world issues and practical experiences will collide, jointly defining new paths for primary healthcare in the active health era.